Augmentation of platelet and endothelial cell enos activity decreases sepsis-related neutrophil-endothelial cell interactions

Shock

Volumn 33, Issue 3, 2010, Pages 242-246

  Khan, Raymond ^a   Kirschenbaum, Linda A ^a   Larow, Catherine ^a   Berna, Gioiamaria ^a   Griffin, Kelly ^a   Astiz, Mark E ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

Downregulation; Endothelium; INOS; Microvascular; NO

Indexed keywords

ACETAMIDE DERIVATIVE; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYLACETAMIDE]ETHANIMIDAMIDE; N(G) METHYLARGININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ADHESION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; NEUTROPHIL; SEPSIS; SEPTIC SHOCK; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; AGED; ARGININE; ENDOTHELIAL CELLS; HUMANS; IMINES; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; PLATELET ACTIVATION; PLATELET AGGREGATION; SHOCK, SEPTIC;

EID: 77149159102     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181b0f96f     Document Type: Article

References (34)

1. Astiz ME, DeGent G, Rackow EC: Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 23:265-271, 1995.
2. DeBacker D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166:98-101, 2002.
3. Kirschenbaum LA, McKevitt D, Rullan M, Reisbeck B, Fujii T, Astiz ME: Importance of platelets and fibrinogen in neutrophilYendothelial cell interactions in septic shock. Crit Care Med 32:1904-1909, 2004.
4. Opal S: Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 28:S77-S81, 2000.
5. Vincent JL, Zhang H, Szabo C, Preiser JC: Effect of nitric oxide in septic shock. Am J Respir Crit Care Med 181:1781-1785, 2000.
6. Moncada S: Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 811:60-67, 1997.
7. Wu F, Wilson JX, Tyml K: Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic Biol Med 37:1282-1289, 2004.
8. Gocan N, Scott J, Tyml K: Nitric oxide produced by neuronal NOS may impair vasodilation in septic rat skeletal muscle. Am J Physiol 278: H1480-H1489, 2000.
9. Kubes P, Suzuki M, Granger D: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 88:4651-4655, 1991.
10. Hickey M, Kubes P: Role of nitric oxide in regulation of leukocyte-endothelial cell interactions. Exp Physiol 82:339-348, 1997.
11. Gkaliagkousi E, Ritter J, Ferro A: Platelet-derived nitric oxide signaling and regulation. Circ Res 101:654-662, 2007.
12. Liaudet L, Rosselet A, Schaller, Perret C, Feihel F: Non-selective versus selective inhibition of inducible nitric oxide synthase in experimental septic shock. J Infect Dis 177:127-132, 1998.
13. Klemm K, Moody F: Regional intestinal blood flow and nitric oxide synthesis in the rats. Ann Surg 227:1126-1133, 1998.
14. Spain D, Wilson M, Bar-Natan MF, Garrison R: Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfu-sion of bacteremia. J Trauma 36:720-725, 1994.
15. Lopez A, Lorente J, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Multiple-center randomized, placebo-controlled, double-blind study of nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30, 2004.
16. Searles C: Transcriptional and postranscriptional regulation of endothelial nitric oxide synthase expression. Am J Cell Physiol 291:C803-C816, 2006.
17. Southban G, Szabo C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 151:383-394, 1996.
18. ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of vasoactive therapies in sepsis. Crit Care Med 20:864-874, 1992.
19. Cooke BM, Usami S, Perry I, Nash GB: A simplified method for the culture of endothelial cells and analysis of adhesion of blood cells under conditions of flow. Microvasc Res 45:33-45, 1993.
20. 2 balance in pigs. Intensive Care Med 31:985-992, 2005.
21. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson C, Blantz R: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rates. J Clin Invest 100:439-448, 1997.
22. Sundrani R, Easington C, Matto A, Parrillo J, Hollenberg S: Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Crit Care Med 28:2898-2903, 2000.
23. Garvey E, Oplinger J, Furfine E, Kiff R, Laszlo F, Whittle B, Knowles R: 1400W is a slow, tight blinding, and highly selective inhibitor of inducible nitric-oxide in vitro and in vivo. J Biol Chem 272:4959-4963, 1997.
24. Nishida J, McCuskey R, McDonnell D, Fox E: Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267: G1135-G1141, 1994.
25. Neviere R, Mordon S, Marechal X, Buys B, Guery B, Mathieu D, Wattel F, Chopin C: Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med 28:1072-1076, 2000.
26. Salter J, Kriegstein C, Issekutz A, Granger N: Platelets modulate ischemia/ reperfusionYinduced leukocyte recruitment in the mesenteric circulation. Am J Physiol 281:G1432-G1439, 2001.
27. Carvalho-Taveres J, Hickey M, Hutchinson J, Sutcliffe I, Kubes P: A role for platelets and endothelial selectins in tumor necrosis factor-!Yinduced leukocyte recruitment in the brain microvasculature. Circ Res 87:1141-1148, 2000.
28. Maeda T, Nash G, Christopher B, Pecsvarady L, Dormandy J: Platelet-induced granulocyte aggregation in vitro. Blood Coagul Fibrinolysis 2:699-703, 1991.
29. Randriamboavonjy V, Fleming I: Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there? Pharmacol Rep 57 (suppl):59-652005.
30. Freedman J, Loscalzo J, Barnard M, Alpert C, Keaney J, Michelson A: Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100:350-356, 1997.
31. Goubareva I, Gkalagkousi E, Shah A, Queen L, Ritter J, Ferro A: Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. Cardiovasc Res 75: 793-802, 2007.
32. Bateman R, Sharpe M, Goldman D, Lidington D, Ellis C: Inhibiting nitric oxide over production during hypotensive sepsis increases local oxygen consumption in rat skeletal muscle. Crit Care Med 36:225-231, 2008.
33. Reade M, Millio J, Younf J, Boyd A: Nitric oxide synthase is downregulated, while haem oxygenase is increased in patients with septic shock. Br J Anaesth 94:468-473, 2005.
34. Reedman J, Ting B, Hankin B, Loscalzo J, Keaney J, Vita J: Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation 98:1481-1486, 1998